
FDA Watch: CND Life Sciences Wins Breakthrough Device Designation for Skin-Based Neurodegenerative Test
The Syn-One assay can diagnose multiple conditions without needing a lumbar puncture

The Syn-One assay can diagnose multiple conditions without needing a lumbar puncture

FDA-approved tests like Intellisep and TriVerity demonstrate potential for early sepsis diagnosis

Join G2 Intelligence for this interactive discussion about whether clinical immunohistochemistry testing should be a stain or an assay, with our experts offering arguments for and against the proposed changes

Join us and our experts to learn how labs can reimagine infrastructure utilization through collaboration to improve health system finances and enrich their value proposition

Research reveals that diagnostic error in the US may cause up to 800,000 serious outcomes annually.